
5-Amino-1mq
Research use only.
High-purity research-grade 5-Amino-1MQ
5-Amino-1MQ is a small-molecule compound widely studied for its potential role in metabolic regulation and body composition support. Research interest in 5-Amino-1MQ primarily centers around its activity as a nicotinamide N-methyltransferase (NNMT) inhibitor, a pathway associated with cellular energy balance, fat metabolism, and metabolic efficiency. It is commonly explored in preclinical research for its potential effects on adipose tissue reduction, energy expenditure, and overall metabolic function.
Product overview
5-Amino-1MQ is an orally bioavailable NNMT inhibitor designed for enhanced metabolic research applications. NNMT is an enzyme involved in methylation processes and cellular energy regulation, and elevated NNMT activity has been associated with obesity, insulin resistance, and metabolic dysfunction in various experimental models. By inhibiting NNMT activity, 5-Amino-1MQ has demonstrated promising effects in studies involving fat metabolism, energy utilization, and weight management support.
Key research features
Supports metabolic activity: Research suggests 5-Amino-1MQ may help enhance cellular energy expenditure and improve metabolic efficiency by modulating NNMT-related pathways. Preclinical findings indicate potential support for increased calorie utilization and reduced fat accumulation.
Body composition support: Studies indicate 5-Amino-1MQ may assist in reducing adipose tissue mass while supporting lean body composition. Experimental models have demonstrated decreases in body fat accumulation without significant reductions in food intake, making it a compound of interest in metabolic and obesity-related research.
Cellular energy regulation: By influencing NAD+ metabolism and methylation pathways, 5-Amino-1MQ has been investigated for its potential role in optimizing mitochondrial activity and overall cellular energy production. This mechanism may contribute to improved metabolic resilience and energy balance.
Research applications in metabolic health: Early research has explored the potential utility of 5-Amino-1MQ in models involving obesity, insulin resistance, and age-related metabolic decline. Ongoing studies continue to evaluate its broader role in metabolic optimization and longevity-focused research.
5-Amino-1MQ Suggested Use:
Typical Dose: 50–150 mg per day
Route: Oral
Frequency: 1–3 times daily
Duration: 4–8 weeks, or as recommended by a healthcare professional